Blockade of CRF1 or V1b receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression

Richard Alonso, Guy Griebel, G Pavone, +3

Molecular Psychiatry

PsychoneuroimmunologyDevelopmental BiologyMolecular NeuroscienceStress HormoneV1b Receptors +13

Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents

Guy Griebel, Jeanne Stemmelin, B. Scatton

Biological Psychiatry

Cannabis UsePsychoactive DrugEmotional ReactivityBehavioral NeuroscienceAddiction +11

SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (II) Efficacy in Experimental Models Predictive of Activity Against Cognitive Symptoms of Schizophrenia

Philippe Pichat, Olivier Bergis, Jean-Paul Terranova, +11

Neuropsychopharmacology

PsychiatryPsychotic DisorderMedicineExperimental Models PredictiveNicotine +8

Neurochemical, Electrophysiological and Pharmacological Profiles of the Selective Inhibitor of the Glycine Transporter-1 SSR504734, a Potential New Type of Antipsychotic

Ronan Depoortère, Gihad Dargazanli, Genevieve Estenne‐Bouhtou, +27

Neuropsychopharmacology

NeurophysiologyMedicineGlycine Transporter-1 Ssr504734Selective InhibitorPsychopharmacology +10

Stimulation of the β3-Adrenoceptor as a Novel Treatment Strategy for Anxiety and Depressive Disorders

Jeanne Stemmelin, Caroline Cohen, Jean-Paul Terranova, +13

Neuropsychopharmacology

Depressive DisordersNovel Treatment StrategyPsychiatryMedicineNeuroendocrine Mechanism +9

Immunohistochemical and neurochemical correlates of learning deficits in aged rats

Jeanne Stemmelin, Christine Lazarus, Suzanne L. Cassel, +2

Neuroscience

NeuropsychologyCognitive ScienceAgingBrain FunctionBehavioral Neuroscience +8

Evidence that the Lateral Septum is Involved in the Antidepressant-Like Effects of the Vasopressin V1b Receptor Antagonist, SSR149415

Jeanne Stemmelin, Ludovit Lukovic̆, Nicolas Salomé, +1

Neuropsychopharmacology

PsychiatryBehavioral NeuroscienceNeurophysiologyAntidepressant-like EffectsPhysiology +10

The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer’s disease in rodents

Guy Griebel, Jeanne Stemmelin, Mati Lopez‐Grancha, +9

Scientific Reports

Differential roles of amygdaloid nuclei in the anxiolytic- and antidepressant-like effects of the V1b receptor antagonist, SSR149415, in rats

Nuno Salomé, Jeanne Stemmelin, Caroline Cohen, +1

Psychopharmacology

V1b Receptor AntagonistAmygdaloid NucleiPsychiatryBehavioral NeuroscienceNeuroanatomy +12

Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia☆

Denis Boulay, Philippe Pichat, Gihad Dargazanli, +7

Pharmacology Biochemistry and Behavior

Molecular PharmacologyPsychiatryGlycine Transporter-1MedicinePsychotropic Medication +9